-
公开(公告)号:US20230295286A1
公开(公告)日:2023-09-21
申请号:US18020449
申请日:2021-11-24
IPC分类号: C07K16/22 , C12N15/115 , C12N15/113 , A61P35/00
CPC分类号: C07K16/22 , C12N15/115 , C12N15/1136 , A61P35/00 , C12N2310/16 , C12N2310/14 , C12N2310/11
摘要: A pharmaceutical composition for preventing or treating cystic lymphangioma comprising an agent that causes suppression of expression of amphiregulin, suppression of secretion of amphiregulin, and/or inhibition of binding of amphiregulin with an amphiregulin receptor, or an agent that causes suppression of expression of an amphiregulin receptor, suppression of activation of an amphiregulin receptor, and/or inhibition of binding of an amphiregulin receptor with amphiregulin, as an active ingredient.